The immune landscape of common CNS malignancies: implications for immunotherapy

Keyphrases

• Blood-brain Barrier 50%
• Brain Metastases 50%
• Central Nervous System Malignancies 50%
• Central Nervous System Tumors 50%
• CNS Malignancies 100%
• Composition Function 50%
• Difficult-to-treat 50%
• Genetically Engineered Mouse Models 50%
• Glioblastoma 50%
• Glioma 100%
• Immune Cell Function 50%
• Immune Cell Interactions 50%
• Immune Checkpoint Inhibitors 50%
• Immune Composition 50%
• Immune Landscape 100%
• Immune Parameters 50%
• Immune Profiling 50%
• Immunobiology 50%
• Immunotherapeutic Strategy 50%
• Lymphatic Drainage 50%
• Mass Cytometry 50%
• Novel Immunotherapy 50%
• Single-cell RNA Sequencing (scRNA-seq) 50%
• Therapeutic Response 50%

Medicine and Dentistry

• Blood Brain Barrier 33%
• Brain Metastasis 33%
• Cancer 100%
• Cell Composition 33%
• Cell Function 33%
• Cell Interaction 33%
• Central Nervous System 33%
• Central Nervous System Tumor 33%
• Ganglioglioma 66%
• Glioblastoma 33%
• Immune Checkpoint Inhibitor 33%
• Immunocompetent Cell 33%
• Immunology 33%
• Immunotherapy 100%
• Lymphatic Drainage 33%
• Malignant Neoplasm 66%
• Mass Cytometry 33%
• Treatment Response 33%

Immunology and Microbiology

• Blood Brain Barrier 33%
• Cell Composition 33%
• Cell Function 33%
• Cell Interaction 33%
• Central Nervous System 66%
• Genetically Engineered Mouse Strain 33%
• Immune Landscape 100%
• Immunocompetent Cell 33%
• Immunology 33%
• Immunotherapy 100%
• Lineages 33%
• Lymphatic Drainage 33%
• Mass Cytometry 33%
• Mouse Model 33%
• Single-Cell Sequencing 33%